2.2. Patients’ Baseline Demographics and General Features
high-grade, tumors
DISEASE, TUMORS
In total, 44 patients who met the inclusion criteria were subjected to treatment with OncoTheradMost patients (84.1%) had previously undergone two courses of intravesical BCG therapy, as shown in With respect to initial disease staging and histological grading after BCG and/or intravesical chemotherapy treatment, tumors’ prevalence was categorized as high-grade pTa (56.8%, The mean number of relapses after prior BCG and/or intravesical chemotherapy with gemcitabine was 2.2 relapses per patient (